Search research articles
Contact Us
Filters
Showing results (441-450 of 469) with videos related to
Page
of 47
Sort By:
Journal of Orthopaedic Surgery (Hong Kong)
|
December 23, 2020
Consensus statement on diagnosis and treatment of cervical ossification of posterior longitudinal ligament from Asia Pacific Spine Society (APSS) 2020
Xiao-Fei Sun, Yuan Wang, Jing-Chuan Sun, et al.
Journal of Cancer Research and Clinical Oncology
|
December 20, 2003
A decade's studies on metastasis of hepatocellular carcinoma
Zhao-You Tang, Sheng-Long Ye, Yin-Kun Liu, et al.
Oncotarget
|
January 13, 2016
Generation and characterization of a tetraspanin CD151/integrin α6β1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCC
Ai-Wu Ke, Peng-Fei Zhang, Ying-Hao Shen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
April 3, 2004
[Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor]
Zheng-gang Ren, Zhi-ying Lin, Jing-lin Xia, et al.
Acta Cardiologica Sinica
|
April 29, 2016
Coronary Diameters in Taiwanese Children Younger than 6 Years Old: Z-Score Regression Equations Derived from Body Surface Area
Ming-Tai Lin, Chin-Hao Chang, Wen-Chin Hsieh, et al.
Journal of Hematology & Oncology
|
January 25, 2018
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
Man-Qing Cao, A-Bin You, Xiao-Dong Zhu, et al.
Engineering (Beijing, China)
|
December 7, 2020
Development and Validation of a Prognostic Risk Score System for COVID-19 Inpatients: A Multi-Center Retrospective Study in China
Ye Yuan, Chuan Sun, Xiuchuan Tang, et al.
Theranostics
|
August 2, 2019
Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors
Jia-Cheng Lu, Hai-Ying Zeng, Qi-Man Sun, et al.
The Lancet. Oncology
|
June 5, 2023
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
James J Harding, Jia Fan, Do-Youn Oh, et al.
Hepatology (Baltimore, Md.)
|
February 26, 2026
Deep learning-assisted tumor radiomic dynamics on MRI predict pathological complete response in HCC undergoing immune-based therapy followed by hepatectomy
Shi-Qi Zhou, Lu-Na Wang, Li-Fang Wu, et al.
Page
of 47
Search research articles
Search
Showing results (441-450 of 469) with videos related to
Sort By:
Page
of 47
Journal of Orthopaedic Surgery (Hong Kong)
|
December 23, 2020
Consensus statement on diagnosis and treatment of cervical ossification of posterior longitudinal ligament from Asia Pacific Spine Society (APSS) 2020
Xiao-Fei Sun, Yuan Wang, Jing-Chuan Sun, et al.
Journal of Cancer Research and Clinical Oncology
|
December 20, 2003
A decade's studies on metastasis of hepatocellular carcinoma
Zhao-You Tang, Sheng-Long Ye, Yin-Kun Liu, et al.
Oncotarget
|
January 13, 2016
Generation and characterization of a tetraspanin CD151/integrin α6β1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCC
Ai-Wu Ke, Peng-Fei Zhang, Ying-Hao Shen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
April 3, 2004
[Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor]
Zheng-gang Ren, Zhi-ying Lin, Jing-lin Xia, et al.
Acta Cardiologica Sinica
|
April 29, 2016
Coronary Diameters in Taiwanese Children Younger than 6 Years Old: Z-Score Regression Equations Derived from Body Surface Area
Ming-Tai Lin, Chin-Hao Chang, Wen-Chin Hsieh, et al.
Journal of Hematology & Oncology
|
January 25, 2018
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
Man-Qing Cao, A-Bin You, Xiao-Dong Zhu, et al.
Engineering (Beijing, China)
|
December 7, 2020
Development and Validation of a Prognostic Risk Score System for COVID-19 Inpatients: A Multi-Center Retrospective Study in China
Ye Yuan, Chuan Sun, Xiuchuan Tang, et al.
Theranostics
|
August 2, 2019
Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors
Jia-Cheng Lu, Hai-Ying Zeng, Qi-Man Sun, et al.
The Lancet. Oncology
|
June 5, 2023
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
James J Harding, Jia Fan, Do-Youn Oh, et al.
Hepatology (Baltimore, Md.)
|
February 26, 2026
Deep learning-assisted tumor radiomic dynamics on MRI predict pathological complete response in HCC undergoing immune-based therapy followed by hepatectomy
Shi-Qi Zhou, Lu-Na Wang, Li-Fang Wu, et al.
Page
of 47